Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

Share Price Information for Clean Power Hyd (CPH2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.25
Bid: 12.00
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 0.50 (4.167%)
Open: 12.25
High: 12.25
Low: 12.25
Prev. Close: 12.25
CPH2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operations Update

29 Apr 2022 10:16

RNS Number : 8700J
Clean Power Hydrogen
29 April 2022
 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

29 April 2022

 

Clean Power Hydrogen Plc

("CPH2", the "Company" or the "Group")

 

Operations Update

 

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), provides an update regarding commissioning and delivery of its first MFE220 unit where the Group is experiencing delays. These delays are, in part, being caused by supplier issues, similar to those that are being experienced across a number of sectors as a result of the Covid-19 pandemic and the current economic environment, which in turn have impacted the planned commissioning schedule. Additionally, there are a number of processes, including engineering modifications, that have taken longer than expected to finalise. However, none of these engineering modifications concern the overall viability of the design and the Group is fully expecting to overcome these matters in the next few months.

 

The Company continues to progress its sales pipeline and licensing work streams, recently announcing two additional sales (ATOME and AFCyro). CPH2's pipeline continues to grow with additional contracts expected once the first MFE220 has completed its Factory Acceptance Testing ("FAT") and is in operation at the customer's site.

Following the successful IPO, CPH2 has invested significantly in its workforce, specifically in its engineering head count with ten additional process, mechanical, and electrical engineers joining imminently, and a new head of production has been identified and will join in due course.

 

Jon Duffy, Chief Executive Officer of CPH2, commented:

 

"Whilst we are disappointed by the delays we are currently experiencing in the commissioning of our first MFE220 unit, the ongoing dialogue with our customer remains positive with a view to resolving the delays as soon as possible. In addition, we remain confident as our pipeline continues to grow. We remain on course to deliver our aims, targeting 4GW production capacity by 2030, and are certain of our ability deliver on the opportunities ahead."

 

 

 

For more information, please contact:

 

Clean Power Hydrogen Plc

via Camarco

Jon Duffy, Chief Executive Officer

Cenkos Securities plc - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3 757 4980

Billy Clegg

Owen Roberts

Monique Perks

Lily Pettifar

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPUCGCUPPUBB
12
Date   Source Headline
19th Apr 20247:00 amRNS2023 Full Year Results
23rd Feb 20247:00 amRNSAwards under Long-Term Incentive Plan
21st Feb 20247:00 amRNSOperational Update
5th Feb 20247:00 amRNSISO Certifications
28th Nov 20237:00 amRNSRevised Agreement with ATOME Energy
20th Nov 20237:00 amRNSChange of Nominated Adviser
2nd Nov 20237:00 amRNSCompany Update
21st Sep 20237:00 amRNSInterim Results
22nd Jun 20237:00 amRNS2023 Save As You Earn Scheme
21st Jun 20231:09 pmRNSResult of AGM
19th Jun 20237:00 amRNSGrant of EMI Options
6th Jun 20237:00 amRNSUpdate on Licence Agreement with GHFG Limited
17th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
28th Apr 202312:16 pmRNSHoldings in Company
26th Apr 20233:26 pmRNSPDMR Dealing
25th Apr 20237:00 amRNSCorporate Presentation
20th Apr 20237:00 amRNSMaiden Financial Results
13th Apr 20237:00 amRNSInvestor Presentation
27th Mar 20237:00 amRNSFabrum Solutions Ltd receives order from Obayashi
16th Mar 20237:00 amRNSPDMR Dealing
27th Feb 20237:00 amRNSLock-in Agreement Extension
8th Feb 20237:00 amRNSSave As You Earn Scheme
31st Jan 20237:00 amRNSManufacturing Agreement with Fabrum Solutions Ltd
26th Jan 20237:00 amRNSAppointment of Chief Technical Officer
22nd Dec 20227:00 amRNSAgreements Signed with Fabrum Solutions Ltd
20th Dec 20221:14 pmRNSHolding(s) in Company
12th Dec 20225:14 pmRNSInvestment in ATOME Energy plc
6th Dec 20227:00 amRNSSenior Management Team Strengthened
22nd Nov 202211:06 amRNSSecond Price Monitoring Extn
22nd Nov 202211:00 amRNSPrice Monitoring Extension
22nd Nov 20229:00 amRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSOperational Update
4th Oct 20224:41 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSInterim results
23rd Sep 20227:00 amRNSInterim results
7th Sep 20224:45 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSAppointment of James Hobson as CFO
5th Sep 20227:00 amRNSAgreement with KCA Deutag Group
24th Aug 20228:11 amRNSOperational Update
19th Jul 20225:55 pmRNSResult of AGM
19th Jul 20227:45 amRNSLicence Agreement with GHFG Ltd.
23rd Jun 20225:24 pmRNSNotice of 2022 Annual General Meeting
27th May 20227:00 amRNSGroup Annual Report and Financial Statements
29th Apr 202210:16 amRNSOperations Update
4th Apr 202212:15 pmRNSAdditional purchase order from existing customer
21st Mar 20227:00 amRNSNew purchase order from additional customer
21st Mar 20227:00 amRNSOperations Update
2nd Mar 20225:31 pmRNSHolding(s) in Company
1st Mar 20224:41 pmRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.